Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Li, Yingxiang ^a   Wang, Xujun ^a   Zheng, Haiyang ^a   Wang, Chengyang ^a   Minvielle, Stéphane ^b   Magrangeas, Florence ^b   Avet Loiseau, Hervé ^b   Shah, Parantu K ^c   Zhang, Yong ^a   Munshi, Nikhil C ^d   Li, Cheng ^a,c  

^a TONGJI UNIVERSITY   (China)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME IMPRINTING; HYDPERDIPLOID MULTIPLE MYELOMA; MICROARRAY ANALYSIS; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; TRISOMY;

GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIPLE MYELOMA; POLYPLOIDY; REPRODUCIBILITY OF RESULTS; TRISOMY;

EID: 84875021648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058809     Document Type: Article

References (22)

1. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC, (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7: 585-598.
2. Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC, (2009) Multiple myeloma. Lancet 374: 324-339.
3. Rajagopalan H, Lengauer C, (2004) Aneuploidy and cancer. Nature 432: 338-341.
4. Chng WJ, Ketterling RP, Fonseca R, (2006) Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma. Genes Chromosomes Cancer 45: 1111-1120.
5. Mohamed AN, Bentley G, Bonnett ML, Zonder J, Al-Katib A, (2007) Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Am J Hematol 82: 1080-1087.
6. Smadja NV, Fruchart C, Isnard F, Louvet C, Dutel JL, et al. (1998) Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. Leukemia 12: 960-969.
7. Anderson KC, Carrasco RD, (2011) Pathogenesis of myeloma. Annu Rev Pathol 6: 249-274.
8. Debes-Marun CS, Dewald GW, Bryant S, Picken E, Santana-Davila R, et al. (2003) Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia 17: 427-436.
9. Fassas AB, Spencer T, Sawyer J, Zangari M, Lee CK, et al. (2002) Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. Br J Haematol 118: 1041-1047.
10. Avet-Loiseau H, Li C, Magrangeas F, Gouraud W, Charbonnel C, et al. (2009) Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol 27: 4585-4590.
11. Chng WJ, Kumar S, Vanwier S, Ahmann G, Price-Troska T, et al. (2007) Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 67: 2982-2989.
12. Broyl A, Hose D, Lokhorst H, de Knegt Y, Peeters J, et al. (2010) Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood 116: 2543-2553.
13. Agnelli L, Fabris S, Bicciato S, Basso D, Baldini L, et al. (2007) Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma. Br J Haematol 136: 565-573.
14. Zhou Y, Zhang Q, Stephens O, Heuck CJ, Tian E, et al. (2012) Prediction of cytogenetic abnormalities with gene expression profiles. Blood 119: e148-150.
15. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
16. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
18. Ripley BD (2008) Pattern recognition and neural networks: Cambridge university press.
19. Venebles WN, Ripley B (1994) Modern applied statistics with S-PLUS. New York: Springer-Verlag.
20. Hertzberg L, Betts DR, Raimondi SC, Schafer BW, Notterman DA, et al. (2007) Prediction of chromosomal aneuploidy from gene expression data. Genes Chromosomes Cancer 46: 75-86.
21. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z, (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38: 1043-1048.
22. Magrangeas F, Avet-Loiseau H, Munshi NC, Minvielle S, (2011) Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood 118: 675-678.